Herpes Markers Testing Market
Herpes Markers Testing Market Study by Viral Culture Test, Nucleic Acid Amplification-Based Kits, and Antibody-Based Kits for HSV-1, HSV-2, and HSV-1/HSV-2 from 2024 to 2034
Analysis of Herpes Markers Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Herpes Markers Testing Market Outlook (2024 to 2034)
The global herpes markers testing market size is predicted to rise at a CAGR of 6.1% and reach US$ 817.5 million by 2034. Due to the increasing incidence of herpes infection, the market for herpes marker testing is anticipated to develop significantly and reach US$ 452.9 million in 2024.
The robust pipeline and active research and development activities are expected to provide excellent growth potential for the global herpes marker testing market. These elements will create numerous chances for market participants to leverage and develop their businesses between 2024 and 2034.
Key Market Growth Drivers
- The rising prevalence of HSV-1 and HSV-2, the herpes simplex virus, drives the need for herpes marker testing. Based on the research of the Public Health Agency of Canada, the seroprevalence of HSV-1 infection is about 100% in undeveloped and underdeveloped countries and above 70% in industrialized countries worldwide.
- The herpes virus is quite common and causes no symptoms, so the market for herpes marker testing is expanding. Since over 80% of herpes infections have no symptoms, doctors must rely on diagnostic testing to diagnose accurately and provide the appropriate therapy.
- Testing for the herpes simplex virus (HSV), formerly done manually, has progressed to automated labs employing sophisticated equipment, including chemical analyzers, enabling more precise and efficient testing techniques. The usage of these techniques drives the global market for herpes testing.
- The herpes marker testing market is experiencing significant growth due to the increasing demand for this diagnostic tool in research clinics worldwide. Accurate detection of herpes markers is crucial for scientists and healthcare professionals, and the market is expected to continue expanding due to technological advancements.
The global market for therapies for the illness is expected to rise primarily owing to the growing prevalence of sexually transmitted diseases and viable pipeline prospects. It is anticipated that this expansion will support the herpes markers testing sector.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 452.9 million |
| Forecasted Market Value (2034F) | US$ 817.5 million |
| Global Market Growth Rate (2024 to 2034) | 6.1% CAGR |
| Antibody Based Kits Segment Growth Rate (2024 to 2034) | 6.1% |
| HSV-1/HSV-2 Segment Growth Rate (2024 to 2034) | 6.5% |
| North America Market Share (2024) | 29.7% |
| East Asia Market Share (2024) | 8.6% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors Have Driven the Global Surge in the Herpes Markers Testing Industry?
“Rising Occurrence of Hospital-Acquired Infections Erupts the Herpes Markers Testing Industry”
Individuals with long-term or chronic illnesses, such as encephalitis and keratitis, are at a heightened risk of contracting the Herpes simplex virus, which can lead to elevated rates of Human immunodeficiency virus (HIV) transmission and acquisition.
The Herpes simplex virus, causing painful blisters and cold sores, necessitates efficient treatment options. The herpes markers testing market focuses on developing diagnostic tests to detect viral antibodies in blood samples. As herpes infections increase globally, demand for these tests is expected to upsurge.
“Growing Rate of Herpes Simplex Virus Fuels Market Expansion”
Neonatal herpes is a potentially fatal condition that can arise from a new-born being exposed to HSV in the vaginal system during delivery. The rising birth rate is advantageous to the market since new-born herpes can cause permanent neurological damage or even infant mortality. It is anticipated that the number of new infections, the rise of clinical research, and technical improvements will propel the market for herpes simplex virus (HSV) testing.
Nonetheless, during the projection period, the herpes simplex virus (HSV) testing market will have more growth opportunities due to the development of precise screening tests and the expansion of the healthcare sector.
Which Factors Present Challenges to the Herpes Markers Testing Market Growth?
“Lack of Awareness towards STD Treatment Spoils Herpes Markers Testing Market Growth”
The global herpes marker testing market is expected to face significant challenges due to stringent government regulations likely to hinder market growth. Additionally, the social stigma attached to sexually transmitted illnesses is a significant barrier to the market's expansion, which is further compounded by increased product recalls.
The scarcity of qualified workers and the restricted availability of labs are two significant obstacles impeding the maturation of the herpes simplex virus (HSV) testing industry. This is anticipated to considerably limit the market's growth throughout the forthcoming decade.
Despite the increasing demand for herpes marker testing, the limited availability of testing facilities and trained professionals pose significant challenges to the market's growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
The herpes relief sector in North America is predicted to develop at a phenomenal annual pace of 6.3% by 2034. It is expected that 73.6% of the United States industry will be accounted for by quick herpes testing in 2024.
In the meanwhile, it is projected that by 2034, the market for sexually transmitted diseases in East Asia will grow at a 5.9% CAGR. With a 49.0% market share, China is expected to command most of East Asia’s herpes marker testing market in 2024.
Why is the United States Dominating the Global Herpes Markers Testing Market?
“Rise in Clinical Trials for STDs Burgeons the United States Herpes Markers Testing Industry”
According to Fact.MR., the demand for herpes testing is expected to grow remarkably in the United States. It is projected to reach a market size of approximately US$ 99 million in 2024. Moreover, a CAGR of 6.4% is expected during the forecast period, which is likely to result in a market worth US$ 184 million by 2034. This reflects a significant expansion in the herpes testing market, indicating a growing need for reliable and accurate disease diagnosis.
When it comes to clinical studies on herpes marker testing, the United States is leading the industry. Modern testing facilities and medical insurance coverage for HSV testing are two other features that set the area apart.
Significant income from the region's share of the global herpes marker testing market is also attributed to the high awareness among people to seek medical testing for symptomatic HSV. The increased severity of Herpes and the increasing number of HIV patients are two further factors driving the rise of the herpes marker testing industry in the United States.
Which Factors Position China as a Thriving Herpes Diagnosis Industry?
“Limited Public Awareness Pushes Chinese Healthcare Sector with Sluggish Pace”
China’s herpes marker testing industry is expected to increase and reach a predicted value of US$ 35 million by 2034. In 2024, it is anticipated that China will account for 49.0% of the East Asian market for herpes markers testing. The market has been expanding gradually in the last few years. From 2024 to 2034, this sector is projected to grow at a 6.2% CAGR.
The public's ignorance of the virus persists in developing nations such as China, severely hindering the herpes marker testing industry. Due to this lack of knowledge, there is little demand for herpes diagnostic testing and little money made.
Public education about the virus is made much more difficult because the issue is exacerbated by a shortage of medical resources and an unstable economy in many locations. As a result, the demand for accessible and trustworthy herpes diagnostic tests that may aid in the early diagnosis of the virus and stop its transmission is developing in large cities such as Beijing and Macao. It is critical to address this issue so that individuals in China may obtain appropriate care, understand the hazards of HSV, and take the necessary steps to protect themselves and others.
Category-wise Insights
The test type of antibody-based kits is predicted to account for 50.2% of the market in 2024. Concurrently, the viral culture test sector would attain 26.0% of the market, considerably augmenting the industry's resource variety and stability.
Preliminary data suggests that in 2024, the HSV-1/HSV-2 segment will have a 48.9% market share for herpes markers testing. In 2024, the HSV-2 category is expected to hold a 27.6% market share and grow at an average annual increase of 5.7%.
Why Is the Herpes Markers Testing Industry Increased Demand for Antibody Based Kits?
“Demand for the Antibody Based Kits Cures the Herpes Markers Testing Industry”
Antibody-based kits dominated the market in 2024 with a 50.2% revenue share. Over the following decade, the antibody-based kits category is expected to increase most rapidly, with an overall growth rate of 6.1%. The category of antibody-based Kits had a valuation of US$ 227.5 million in 2024.
The demand for antibody-based kits in the herpes markers testing market is rising due to the increased necessity for precise and effective diagnostic tools. These kits are essential for identifying herpes indicators and giving medical personnel a trustworthy way to recognize and treat herpes infections.
The rising use of antibody-based tests is partly due to greater awareness of STDs and the need for early detection. Because of their ease of use, sensitivity and specificity are essential for raising test accuracy, supporting prompt treatments, and improving patient outcomes. This growing demand highlights how important antibody-based kits are to advancing herpes diagnoses.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
The demand for herpes treatments is expected to rise due to industry players investing in research and development, expanding their product offerings, and strategic initiatives like new product launches, mergers, acquisitions, higher investment, and collaborations. The herpes markers testing industry must offer reasonably priced products to survive in a competitive market.
Major treatment manufacturers aim to increase sales and global demand for their STD medicines by obtaining FDA clearance and collaborating with regional distribution partners. Local manufacturing is a critical business approach in the global herpes treatment industry, reducing operational costs, benefiting consumers, and increasing market share.
- In October 2023, Gilead Sciences and Assembly Biosciences collaborated to discover new antiviral treatments, initially concentrating on Assembly Bio's well-established areas of hepatitis B, HDV, and herpesviruses.
- In August 2023, David Chu and Uma Singh from the University of Georgia developed and patented a chemical that could potentially treat varicella-zoster virus, herpes-causing shingles, and chickenpox.
Segmentation of Herpes Markers Testing Market
-
By Test Type:
- Viral Culture Test
- Nucleic Acid Amplification Based Kits
- Antibody Based Kits
-
By Indication:
- HSV-1
- HSV-2
- HSV-1/HSV-2
-
By Application:
- Research Use
- Clinical Diagnostics
-
By End User:
- Hospitals
- Diagnostics Centers
- Clinics
- Academic & Research Institutes
-
By Region:
- North America
- Europe
- East Asia
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019-2023 and Forecast, 2024-2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019-2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024-2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Test Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2019-2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2024-2034 5.3.1. Viral Culture Test 5.3.2. Nucleic Acid Amplification-based Kits 5.3.3. Antibody/Antigen-based Kits 5.4. Y-o-Y Growth Trend Analysis By Test Type, 2019-2023 5.5. Absolute $ Opportunity Analysis By Test Type, 2024-2034 6. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2019-2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2024-2034 6.3.1. HSV-1 6.3.2. HSV-2 6.3.3. HSV-1/HSV-2 6.4. Y-o-Y Growth Trend Analysis By Indication, 2019-2023 6.5. Absolute $ Opportunity Analysis By Indication, 2024-2034 7. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2019-2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2024-2034 7.3.1. Research-Use 7.3.2. Clinical Diagnostics 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023 7.5. Absolute $ Opportunity Analysis By Application , 2024-2034 8. Global Market Analysis 2019-2023 and Forecast 2024-2034, By End Users 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End Users, 2019-2023 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Users, 2024-2034 8.3.1. Hospitals 8.3.2. Diagnostic Centres 8.3.3. Clinics 8.3.4. Academic & Research Institutes 8.4. Y-o-Y Growth Trend Analysis By End Users, 2019-2023 8.5. Absolute $ Opportunity Analysis By End Users, 2024-2034 9. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019-2023 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024-2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019-2023 and Forecast 2024-2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Test Type 10.2.3. By Indication 10.2.4. By Application 10.2.5. By End Users 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Test Type 10.3.3. By Indication 10.3.4. By Application 10.3.5. By End Users 10.4. Key Takeaways 11. Latin America Market Analysis 2019-2023 and Forecast 2024-2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Test Type 11.2.3. By Indication 11.2.4. By Application 11.2.5. By End Users 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Test Type 11.3.3. By Indication 11.3.4. By Application 11.3.5. By End Users 11.4. Key Takeaways 12. Western Europe Market Analysis 2019-2023 and Forecast 2024-2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Test Type 12.2.3. By Indication 12.2.4. By Application 12.2.5. By End Users 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Test Type 12.3.3. By Indication 12.3.4. By Application 12.3.5. By End Users 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Test Type 13.2.3. By Indication 13.2.4. By Application 13.2.5. By End Users 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Test Type 13.3.3. By Indication 13.3.4. By Application 13.3.5. By End Users 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Test Type 14.2.3. By Indication 14.2.4. By Application 14.2.5. By End Users 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Test Type 14.3.3. By Indication 14.3.4. By Application 14.3.5. By End Users 14.4. Key Takeaways 15. East Asia Market Analysis 2019-2023 and Forecast 2024-2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Test Type 15.2.3. By Indication 15.2.4. By Application 15.2.5. By End Users 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Test Type 15.3.3. By Indication 15.3.4. By Application 15.3.5. By End Users 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2034, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Test Type 16.2.3. By Indication 16.2.4. By Application 16.2.5. By End Users 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Test Type 16.3.3. By Indication 16.3.4. By Application 16.3.5. By End Users 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. U.S. 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2023 17.1.2.1. By Test Type 17.1.2.2. By Indication 17.1.2.3. By Application 17.1.2.4. By End Users 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2023 17.2.2.1. By Test Type 17.2.2.2. By Indication 17.2.2.3. By Application 17.2.2.4. By End Users 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2023 17.3.2.1. By Test Type 17.3.2.2. By Indication 17.3.2.3. By Application 17.3.2.4. By End Users 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2023 17.4.2.1. By Test Type 17.4.2.2. By Indication 17.4.2.3. By Application 17.4.2.4. By End Users 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2023 17.5.2.1. By Test Type 17.5.2.2. By Indication 17.5.2.3. By Application 17.5.2.4. By End Users 17.6. U.K. 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2023 17.6.2.1. By Test Type 17.6.2.2. By Indication 17.6.2.3. By Application 17.6.2.4. By End Users 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2023 17.7.2.1. By Test Type 17.7.2.2. By Indication 17.7.2.3. By Application 17.7.2.4. By End Users 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2023 17.8.2.1. By Test Type 17.8.2.2. By Indication 17.8.2.3. By Application 17.8.2.4. By End Users 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2023 17.9.2.1. By Test Type 17.9.2.2. By Indication 17.9.2.3. By Application 17.9.2.4. By End Users 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2023 17.10.2.1. By Test Type 17.10.2.2. By Indication 17.10.2.3. By Application 17.10.2.4. By End Users 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2023 17.11.2.1. By Test Type 17.11.2.2. By Indication 17.11.2.3. By Application 17.11.2.4. By End Users 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2023 17.12.2.1. By Test Type 17.12.2.2. By Indication 17.12.2.3. By Application 17.12.2.4. By End Users 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2023 17.13.2.1. By Test Type 17.13.2.2. By Indication 17.13.2.3. By Application 17.13.2.4. By End Users 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2023 17.14.2.1. By Test Type 17.14.2.2. By Indication 17.14.2.3. By Application 17.14.2.4. By End Users 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2023 17.15.2.1. By Test Type 17.15.2.2. By Indication 17.15.2.3. By Application 17.15.2.4. By End Users 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2023 17.16.2.1. By Test Type 17.16.2.2. By Indication 17.16.2.3. By Application 17.16.2.4. By End Users 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2023 17.17.2.1. By Test Type 17.17.2.2. By Indication 17.17.2.3. By Application 17.17.2.4. By End Users 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2023 17.18.2.1. By Test Type 17.18.2.2. By Indication 17.18.2.3. By Application 17.18.2.4. By End Users 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2023 17.19.2.1. By Test Type 17.19.2.2. By Indication 17.19.2.3. By Application 17.19.2.4. By End Users 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2023 17.20.2.1. By Test Type 17.20.2.2. By Indication 17.20.2.3. By Application 17.20.2.4. By End Users 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2023 17.21.2.1. By Test Type 17.21.2.2. By Indication 17.21.2.3. By Application 17.21.2.4. By End Users 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2023 17.22.2.1. By Test Type 17.22.2.2. By Indication 17.22.2.3. By Application 17.22.2.4. By End Users 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2023 17.23.2.1. By Test Type 17.23.2.2. By Indication 17.23.2.3. By Application 17.23.2.4. By End Users 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Test Type 18.3.3. By Indication 18.3.4. By Application 18.3.5. By End Users 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Abbott Laboratories 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Abcam Plc 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Thermo Fisher Scientific, Inc. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. DiaSorin S.p.A. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Quidel Corporation 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Luminex Corporation 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Merck KGaA 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Qiagen N.V 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Hologic Inc 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Bio Rad Laboratories Inc 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019-2034
Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 3: Global Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 4: Global Market Value (US$ Million) Forecast by Application , 2019-2034
Table 5: Global Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 6: North America Market Value (US$ Million) Forecast by Country, 2019-2034
Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 8: North America Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 9: North America Market Value (US$ Million) Forecast by Application , 2019-2034
Table 10: North America Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2019-2034
Table 12: Latin America Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 13: Latin America Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 14: Latin America Market Value (US$ Million) Forecast by Application , 2019-2034
Table 15: Latin America Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 16: Western Europe Market Value (US$ Million) Forecast by Country, 2019-2034
Table 17: Western Europe Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 18: Western Europe Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Application , 2019-2034
Table 20: Western Europe Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 21: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019-2034
Table 22: Eastern Europe Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 23: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 24: Eastern Europe Market Value (US$ Million) Forecast by Application , 2019-2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 26: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019-2034
Table 27: South Asia and Pacific Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 28: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 29: South Asia and Pacific Market Value (US$ Million) Forecast by Application , 2019-2034
Table 30: South Asia and Pacific Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 31: East Asia Market Value (US$ Million) Forecast by Country, 2019-2034
Table 32: East Asia Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 33: East Asia Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 34: East Asia Market Value (US$ Million) Forecast by Application , 2019-2034
Table 35: East Asia Market Value (US$ Million) Forecast by End Users, 2019-2034
Table 36: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019-2034
Table 37: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 38: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2019-2034
Table 39: Middle East and Africa Market Value (US$ Million) Forecast by Application , 2019-2034
Table 40: Middle East and Africa Market Value (US$ Million) Forecast by End Users, 2019-2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Test Type, 2024-2034
Figure 2: Global Market Value (US$ Million) by Indication, 2024-2034
Figure 3: Global Market Value (US$ Million) by Application , 2024-2034
Figure 4: Global Market Value (US$ Million) by End Users, 2024-2034
Figure 5: Global Market Value (US$ Million) by Region, 2024-2034
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2019-2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024-2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024-2034
Figure 9: Global Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 12: Global Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 13: Global Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 14: Global Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 15: Global Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 16: Global Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 17: Global Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 18: Global Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 21: Global Market Attractiveness by Test Type, 2024-2034
Figure 22: Global Market Attractiveness by Indication, 2024-2034
Figure 23: Global Market Attractiveness by Application , 2024-2034
Figure 24: Global Market Attractiveness by End Users, 2024-2034
Figure 25: Global Market Attractiveness by Region, 2024-2034
Figure 26: North America Market Value (US$ Million) by Test Type, 2024-2034
Figure 27: North America Market Value (US$ Million) by Indication, 2024-2034
Figure 28: North America Market Value (US$ Million) by Application , 2024-2034
Figure 29: North America Market Value (US$ Million) by End Users, 2024-2034
Figure 30: North America Market Value (US$ Million) by Country, 2024-2034
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 34: North America Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 37: North America Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 38: North America Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 39: North America Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 40: North America Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 41: North America Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 42: North America Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 43: North America Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 44: North America Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 45: North America Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 46: North America Market Attractiveness by Test Type, 2024-2034
Figure 47: North America Market Attractiveness by Indication, 2024-2034
Figure 48: North America Market Attractiveness by Application , 2024-2034
Figure 49: North America Market Attractiveness by End Users, 2024-2034
Figure 50: North America Market Attractiveness by Country, 2024-2034
Figure 51: Latin America Market Value (US$ Million) by Test Type, 2024-2034
Figure 52: Latin America Market Value (US$ Million) by Indication, 2024-2034
Figure 53: Latin America Market Value (US$ Million) by Application , 2024-2034
Figure 54: Latin America Market Value (US$ Million) by End Users, 2024-2034
Figure 55: Latin America Market Value (US$ Million) by Country, 2024-2034
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 59: Latin America Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 62: Latin America Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 65: Latin America Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 68: Latin America Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 71: Latin America Market Attractiveness by Test Type, 2024-2034
Figure 72: Latin America Market Attractiveness by Indication, 2024-2034
Figure 73: Latin America Market Attractiveness by Application , 2024-2034
Figure 74: Latin America Market Attractiveness by End Users, 2024-2034
Figure 75: Latin America Market Attractiveness by Country, 2024-2034
Figure 76: Western Europe Market Value (US$ Million) by Test Type, 2024-2034
Figure 77: Western Europe Market Value (US$ Million) by Indication, 2024-2034
Figure 78: Western Europe Market Value (US$ Million) by Application , 2024-2034
Figure 79: Western Europe Market Value (US$ Million) by End Users, 2024-2034
Figure 80: Western Europe Market Value (US$ Million) by Country, 2024-2034
Figure 81: Western Europe Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 84: Western Europe Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 87: Western Europe Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 90: Western Europe Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 93: Western Europe Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 94: Western Europe Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 96: Western Europe Market Attractiveness by Test Type, 2024-2034
Figure 97: Western Europe Market Attractiveness by Indication, 2024-2034
Figure 98: Western Europe Market Attractiveness by Application , 2024-2034
Figure 99: Western Europe Market Attractiveness by End Users, 2024-2034
Figure 100: Western Europe Market Attractiveness by Country, 2024-2034
Figure 101: Eastern Europe Market Value (US$ Million) by Test Type, 2024-2034
Figure 102: Eastern Europe Market Value (US$ Million) by Indication, 2024-2034
Figure 103: Eastern Europe Market Value (US$ Million) by Application , 2024-2034
Figure 104: Eastern Europe Market Value (US$ Million) by End Users, 2024-2034
Figure 105: Eastern Europe Market Value (US$ Million) by Country, 2024-2034
Figure 106: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 112: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 115: Eastern Europe Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 118: Eastern Europe Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 121: Eastern Europe Market Attractiveness by Test Type, 2024-2034
Figure 122: Eastern Europe Market Attractiveness by Indication, 2024-2034
Figure 123: Eastern Europe Market Attractiveness by Application , 2024-2034
Figure 124: Eastern Europe Market Attractiveness by End Users, 2024-2034
Figure 125: Eastern Europe Market Attractiveness by Country, 2024-2034
Figure 126: South Asia and Pacific Market Value (US$ Million) by Test Type, 2024-2034
Figure 127: South Asia and Pacific Market Value (US$ Million) by Indication, 2024-2034
Figure 128: South Asia and Pacific Market Value (US$ Million) by Application , 2024-2034
Figure 129: South Asia and Pacific Market Value (US$ Million) by End Users, 2024-2034
Figure 130: South Asia and Pacific Market Value (US$ Million) by Country, 2024-2034
Figure 131: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 132: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 133: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 134: South Asia and Pacific Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 138: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 139: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 140: South Asia and Pacific Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 141: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 142: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 143: South Asia and Pacific Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 144: South Asia and Pacific Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 145: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 146: South Asia and Pacific Market Attractiveness by Test Type, 2024-2034
Figure 147: South Asia and Pacific Market Attractiveness by Indication, 2024-2034
Figure 148: South Asia and Pacific Market Attractiveness by Application , 2024-2034
Figure 149: South Asia and Pacific Market Attractiveness by End Users, 2024-2034
Figure 150: South Asia and Pacific Market Attractiveness by Country, 2024-2034
Figure 151: East Asia Market Value (US$ Million) by Test Type, 2024-2034
Figure 152: East Asia Market Value (US$ Million) by Indication, 2024-2034
Figure 153: East Asia Market Value (US$ Million) by Application , 2024-2034
Figure 154: East Asia Market Value (US$ Million) by End Users, 2024-2034
Figure 155: East Asia Market Value (US$ Million) by Country, 2024-2034
Figure 156: East Asia Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 157: East Asia Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 158: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 159: East Asia Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 160: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 161: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 162: East Asia Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 165: East Asia Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 166: East Asia Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 167: East Asia Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 168: East Asia Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 169: East Asia Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 170: East Asia Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 171: East Asia Market Attractiveness by Test Type, 2024-2034
Figure 172: East Asia Market Attractiveness by Indication, 2024-2034
Figure 173: East Asia Market Attractiveness by Application , 2024-2034
Figure 174: East Asia Market Attractiveness by End Users, 2024-2034
Figure 175: East Asia Market Attractiveness by Country, 2024-2034
Figure 176: Middle East and Africa Market Value (US$ Million) by Test Type, 2024-2034
Figure 177: Middle East and Africa Market Value (US$ Million) by Indication, 2024-2034
Figure 178: Middle East and Africa Market Value (US$ Million) by Application , 2024-2034
Figure 179: Middle East and Africa Market Value (US$ Million) by End Users, 2024-2034
Figure 180: Middle East and Africa Market Value (US$ Million) by Country, 2024-2034
Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 182: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 183: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 184: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 185: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 186: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 187: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2019-2034
Figure 188: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2024-2034
Figure 189: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2024-2034
Figure 190: Middle East and Africa Market Value (US$ Million) Analysis by Application , 2019-2034
Figure 191: Middle East and Africa Market Value Share (%) and BPS Analysis by Application , 2024-2034
Figure 192: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application , 2024-2034
Figure 193: Middle East and Africa Market Value (US$ Million) Analysis by End Users, 2019-2034
Figure 194: Middle East and Africa Market Value Share (%) and BPS Analysis by End Users, 2024-2034
Figure 195: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Users, 2024-2034
Figure 196: Middle East and Africa Market Attractiveness by Test Type, 2024-2034
Figure 197: Middle East and Africa Market Attractiveness by Indication, 2024-2034
Figure 198: Middle East and Africa Market Attractiveness by Application , 2024-2034
Figure 199: Middle East and Africa Market Attractiveness by End Users, 2024-2034
Figure 200: Middle East and Africa Market Attractiveness by Country, 2024-2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the value of the herpes markers testing market in 2019?
The global herpes markers testing market was worth US$ 336.1 million in 2019.
What is the sales outlook for herpes markers testing in 2024?
The sales outlook for herpes markers testing is likely to be valued at US$ 452.9 million in 2024.
What is the demand forecast for herpes marker testing for the decade?
Demand for herpes markers testing is projected to reach a market value of US$ 817.5 million by the end of 2034.
What is the adoption growth projection for herpes markers testing?
Adoption of herpes markers testing is projected to rise at a CAGR of 6.8% through 2034.
At what rate is the North American market in predicted to grow?
The North American market for herpes markers testing is forecasted to expand at a CAGR of 6.3% through 2034.
Herpes Markers Testing Market